Published in

Korean Endocrine Society, Endocrinology and Metabolism -Korean Endocrine Society-, 4(28), p. 320, 2013

DOI: 10.3803/enm.2013.28.4.320

Links

Tools

Export citation

Search in Google Scholar

A Novel Mutation in the Von Hippel-Lindau Tumor Suppressor Gene Identified in a Patient Presenting with Gestational Diabetes Mellitus

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown
Data provided by SHERPA/RoMEO

Abstract

BackgroundVon Hippel-Lindau (VHL) disease is an autosomal dominantly inherited, multisystemic tumor syndrome caused by mutations in the VHL gene. To date, more than 1,000 germline and somatic mutations of the VHL gene have been reported. We present a novel mutation in the VHL tumor suppressor gene that presented with gestational diabetes mellitus.MethodsA 30-year-old woman presented with gestational diabetes mellitus. She sequentially showed multiple pancreatic cysts, spinal cord hemangioblastoma, cerebellar hemangioblastoma, and clear cell type renal cell carcinomas. Also, her father and brother had brain hemangioblastomas. Each of the three exons of the VHL gene was individually amplified by polymerase chain reaction and direct sequencing was performed using an ABI 3730 DNA analyzer.ResultsDNA sequence analysis to determine the presence of VHL mutation in her family revealed del291C, a novel frameshift mutation.ConclusionWe found a novel mutation in the VHL tumor suppressor gene that presented with gestational diabetes mellitus.